- Clear All
- Remove the2023filter 2023
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theBusiness & economic issuesfilter Business & economic issues
- Remove theProduction medicinefilter Production medicine
- Remove theOne Healthfilter One Health
- Remove theVaccinationfilter Vaccination
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
Artificial intelligence in veterinary medicine: What are the ethical and legal implications?
AVMA Axon recently debuted the webinar "Do No Harm: Ethical and Legal Implications of A.I." by Dr. Dr. Eli Cohen, a clinical professor of diagnostic…
AVMA news
Lawmakers form first-ever Senate Veterinary Medicine Caucus
U.S. Senators Cindy Hyde-Smith and Amy Klobuchar announced August 3 the creation of the inaugural Senate Veterinary Medicine Caucus. It was created to…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
AVMA news
WVC features AVMA sessions, research results
The AVMA offered sessions at the 2023 WVC Annual Conference as part of a year-old partnership with Viticus Group, the organization that hosts WVC.…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
AVMA news
Mars acquires Heska in $1.3B deal
Mars Inc. and Heska Corp. have entered into a agreement that Mars will buy the diagnostic veterinary equipment firm for $1.3 billion.
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
AVMA news
Sales, distribution of medically important antimicrobials remain down for food animals
Annual sales and distribution by volume of medically important antimicrobials for food-producing animals remain down since the substantial decrease in…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
Researcher looking at PFAS exposure in dogs, cats
#AVMA2023 rewind: Per-and-polyfluoroalkyl substances (PFAS) have been linked to harmful health effects in both humans and animals. Dr. Heather D.…
AVMA news
AVMA pledges to 'vigorously defend' against expanding scope of practice
Broadening nonveterinarians' scope of practice would compromise the quality of veterinary care, thus threatening animal and public health, according…
AVMA news
New drug calms cats during transportation, veterinary visits
The Food and Drug Administration (FDA) this November approved Bonqat, a nerve pain medication for cats to alleviate acute anxiety and fear associated…
AVMA news
Leading with lists: How systems boost practice efficiency
Three industry experts shared common roadblocks to improving veterinary practice efficiency during the session “Systems and Processes to Address…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
Here’s one promising approach to address rural veterinary shortages
There are veterinarians who want to work in rural areas of America but are unable to do so—for financial reasons. The great news is that legislation…
AVMA news
Veterinary starting salaries rise in 2023, educational debt holds steady
Mean starting salaries for veterinarians rose to just over $124,295 for graduates entering full-time employment in a year that also saw the mean…
AVMA news
AVMA leaders to discuss environmental sustainability, spectrum of care
Meeting this July in Denver, the AVMA House of Delegates (HOD) will consider new and revised policy proposals dealing with wolf hybrids, tail docking,…